BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32799011)

  • 1. Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis.
    Körtvelyessy P; Goihl A; Guttek K; Schraven B; Prüss H; Reinhold D
    Cytokine; 2020 Nov; 135():155226. PubMed ID: 32799011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
    Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
    Front Immunol; 2021; 12():719432. PubMed ID: 34975832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis.
    Theorell J; Harrison R; Williams R; Raybould MIJ; Zhao M; Fox H; Fower A; Miller G; Wu Z; Browne E; Mgbachi V; Sun B; Mopuri R; Li Y; Waters P; Deane CM; Handel A; Makuch M; Irani SR
    Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2311049121. PubMed ID: 38319973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
    Murayama A; Sugaya K; Hara M; Kawazoe T; Tobisawa S; Nakajima H; Takahashi K
    Intern Med; 2023 Jun; 62(11):1659-1663. PubMed ID: 36223927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.
    Klein CJ; Lennon VA; Aston PA; McKeon A; O'Toole O; Quek A; Pittock SJ
    JAMA Neurol; 2013 Feb; 70(2):229-34. PubMed ID: 23407760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
    Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
    Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
    J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
    Bastiaansen AEM; van Sonderen A; Titulaer MJ
    Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy.
    Dubey D; Britton J; McKeon A; Gadoth A; Zekeridou A; Lopez Chiriboga SA; Devine M; Cerhan JH; Dunlay K; Sagen J; Ramberger M; Waters P; Irani SR; Pittock SJ
    Ann Neurol; 2020 Feb; 87(2):313-323. PubMed ID: 31782181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis.
    Kelly MJ; Grant E; Murchison AG; Binks S; Ramanathan S; Michael S; Handel AE; Handunnetthi L; Uy CE; Soltys JN; Dubey D; Day GS; Lopez-Chiriboga AS; Flanagan EP; Sheerin F; Irani SR
    JAMA Neurol; 2024 May; 81(5):525-533. PubMed ID: 38497971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review.
    Ghimire P; Khanal UP; Gajurel BP; Karn R; Rajbhandari R; Paudel S; Gautam N; Ojha R
    Brain Behav; 2020 Oct; 10(10):e01793. PubMed ID: 32783406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.
    Seery N; Butzkueven H; O'Brien TJ; Monif M
    Autoimmun Rev; 2022 May; 21(5):103074. PubMed ID: 35247644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal epileptogenesis in autoimmune encephalitis.
    Romoli M; Krashia P; Sen A; Franciotta D; Gastaldi M; Nobili A; Mancini A; Nardi Cesarini E; Nigro P; Tambasco N; Mercuri NB; Parnetti L; Di Filippo M; D'Amelio M; Irani SR; Costa C; Calabresi P
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2261-2269. PubMed ID: 31617317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity.
    Tan X; Liu Y; Wu X; Guo Y
    J Neurol; 2022 Nov; 269(11):5893-5900. PubMed ID: 35781606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.
    Nosadini M; Toldo I; Tascini B; Bien CG; Parmeggiani L; De Gaspari P; Zuliani L; Sartori S
    J Neuroimmunol; 2019 Oct; 335():577008. PubMed ID: 31352183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
    Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
    BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.
    Dürr M; Nissen G; Sühs KW; Schwenkenbecher P; Geis C; Ringelstein M; Hartung HP; Friese MA; Kaufmann M; Malter MP; Madlener M; Thaler FS; Kümpfel T; Senel M; Häusler MG; Schneider H; Bergh FT; Kellinghaus C; Zettl UK; Wandinger KP; Melzer N; Gross CC; Lange P; Dreyhaupt J; Tumani H; Leypoldt F; Lewerenz J;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34697224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies.
    Jia Y; Shi H; Ye J; Wang Y
    Clin Neurol Neurosurg; 2020 Oct; 197():106187. PubMed ID: 32911250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
    Michael S; Waters P; Irani SR
    Pract Neurol; 2020 Oct; 20(5):377-384. PubMed ID: 32595134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.